GliaPharm

GliaPharm is a Switzerland-based biotechnology company providing treatments for neurological and psychiatric disorders.GliaPharm's innovative therapeutic approach targets the "support cells" of neurons—glial cells—to sustain and enhance brain metabolism under pathological conditions. Their vision is to become a leading biotechnology company focused on glial-mediated pathways as agents for neuroprotection and cognitive function maintenance.GliaPharm's innovative therapeutic approach is to target glial cells, or the "support cells" of neurons, to support and improve brain metabolism under certain pathological conditions. Their vision is to become a leader in the development of glial-targeted agents that can provide neuroprotection and maintain cognitive function.